Title:
医薬組成物
Document Type and Number:
Japanese Patent JP6826695
Kind Code:
B2
Abstract:
Provided is an oral intestinal tract cleansing agent which reduces the saltiness and bitterness thereof without relying on large amounts of sucralose, has a sulfate which exhibits a strong cleansing effect as an active ingredient thereof and does not incorporate polyethylene glycol therein. Additionally provided is an oral intestinal tract cleansing agent which reduces volume without requiring dilution. A pharmaceutical composition containing sodium sulfate, potassium sulfate and magnesium sulfate as active ingredients, the pharmaceutical composition being characterized by also containing thaumatin or a salt thereof as a sweetener. The pharmaceutical composition is preferably in the form of an aqueous solution, and the concentration of the thaumatin or salt thereof in the aqueous solution is preferably 0.2-10 mg/l, inclusive.
Inventors:
Ayumu Nishioka
Tokuyuki Iwasaki
New Nozomi
Tokuyuki Iwasaki
New Nozomi
Application Number:
JP2020515986A
Publication Date:
February 03, 2021
Filing Date:
December 09, 2019
Export Citation:
Assignee:
Nippon Pharmaceutical Co., Ltd.
International Classes:
A61K33/00; A61K9/08; A61K33/06; A61K47/12; A61K47/18; A61K47/22; A61K47/26; A61K47/42; A61K47/46; A61P1/10
Domestic Patent References:
| JP2014513085A | ||||
| JP2012025732A | ||||
| JP2004339158A |
Foreign References:
| US20150072061 | ||||
| WO2007044681A1 |
Attorney, Agent or Firm:
Nobuaki Kazehaya
Noriko Asano
Noriko Asano